Name

BCAR3 Gene

breast cancer anti-estrogen resistance 3

Breast tumors are initially dependent on estrogens for growth and progression and can be inhibited by anti-estrogens such as tamoxifen. However, breast cancers progress to become anti-estrogen resistant. Breast cancer anti-estrogen resistance gene 3 was identified in the search for genes involved in the development of estrogen resistance. The gene encodes a component of intracellular signal transduction that causes estrogen-independent proliferation in human breast cancer cells. The protein contains a putative src homology 2 (SH2) domain, a hall mark of cellular tyrosine kinase signaling molecules, and is partly homologous to the cell division cycle protein CDC48. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]

bcar3 Gene Set

From GeneRIF Biological Term Annotations

genes co-occuring with the biological term bcar3 in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.

BCAR3 Gene Set

From Pathway Commons Protein-Protein Interactions

interacting proteins for BCAR3 from the Pathway Commons Protein-Protein Interactions dataset.

BCAR3 Gene Set

From LINCS L1000 CMAP CRISPR Knockout Consensus Signatures

genes differentially expressed following the BCAR3 gene perturbation from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.

BL6398 (BCAR3) Gene Set

From NURSA Protein Complexes

proteins in the BL6398 (BCAR3) protein complex recovered by IP-MS from the NURSA Protein Complexes dataset.